From the phase 3 trials at the 9 mg and 12 mg doses: Nausea: 38.1% (9 mg) to 43.2% (12 mg) versus 10.7% with placebo Diarrhea: 34.7% (9 mg) to 33.1% (12 mg) versus 13.4% with placebo Constipation: 21.8% (9 mg) to 25.0% (12 mg) versus 8.7% with placebo Vomiting: 20.4% (9 mg) to 20.9% (12 mg) Compare those numbers to Mounjaro and the difference is clear
It tells you where someone is, not where theyre heading, so that same person, whose body is clearly changing, gets nothing because their number still reads as normal. As Dr
This innovative program uses Semaglutide, an FDA-approved medication renowned for its ability to suppress appetite and regulate hunger, facilitating easier weight management
Cooked vegetables are easier on a gut in transition than raw ones
These drugs have transformed from primarily being used to manage diabetes to a widely sought-after tool for metabolic health and weight loss
For those with mild reflux or IBS, the medication can still be used but requires careful management